| Serial Number | 98199765 |
| Word Mark | TARSUS CONNECT |
| Filing Date | Wednesday, September 27, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Tuesday, March 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 15, 2024 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing healthcare information; Providing medical information to patients and healthcare professionals on medical conditions and the properties and use of pharmaceutical products |
| Description of Mark | The mark consists of the words "TARSUS CONNECT" in which the letter "O" is a stylized representation of an eye. |
| Goods and Services | Providing financial information and assistance to patients and healthcare professionals in the electronic payment and processing options of insurance claims for pharmaceutical products |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 036 |
| First Use Anywhere Date | Tuesday, August 1, 2023 |
| First Use In Commerce Date | Tuesday, August 1, 2023 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, August 1, 2023 |
| First Use In Commerce Date | Tuesday, August 1, 2023 |
| Party Name | Tarsus Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 US |
| Party Name | Tarsus Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 US |
| Event Date | Event Description |
| Saturday, September 30, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 12, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, April 24, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, May 20, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, June 20, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, June 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 23, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Sunday, November 2, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 23, 2025 | USE AMENDMENT FILED |
| Sunday, November 2, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, December 3, 2025 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, December 3, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 3, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 26, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 2, 2026 | ASSIGNED TO LIE |
| Tuesday, March 3, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 3, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 3, 2026 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, March 3, 2026 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |